Concepedia

Amy Bullock

AB

Statistics

Publications

19

Citations

1.2K

H-Index

17

Active since

1988

Affiliations

University of Colorado Boulder(Current)

Institute for Behavioral Medicine

Sage Therapeutics (United States)

Albany Medical Center Hospital

Biogen (United States)

Amy Bullock is an author at University of Colorado Boulder specializing in pharmacology, neuropharmacology, and medicine.

ORCID

Publications per year

1988–2024

19

Publications

19

Zuranolone for the Treatment of Postpartum Depression

Kristina M. Deligiannidis, Samantha Meltzer‐Brody, Bassem Maximos et al. · American Journal of Psychiatry · 2023 · 174 citations

, , +17

Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit.

Michael J. Marks, Paul Whiteaker, Jennifer Calcaterra et al. · PubMed · 1999 · 126 citations

, , +17

Neurosteroids Modulate Nicotinic Receptor Function in Mouse Striatal and Thalamic Synaptosomes

Amy Bullock, Amy L. Clark, Sharon R. Grady et al. · Journal of Neurochemistry · 1997 · 124 citations

, , +15

Inbred mouse strains differ in the regulation of startle and prepulse inhibition of the startle response.

Amy Bullock, Brian S. Slobe, Vimarie Vázquez et al. · Behavioral Neuroscience · 1997 · 113 citations

, , +10

Inbred mouse strains differ in the regulation of startle and prepulse inhibition of the startle response.

Amy Bullock, Brian S. Slobe, Vimarie Vázquez et al. · Behavioral Neuroscience · 1997 · 103 citations

, , +10

1–5 of 19